After Hours Summary: ANY +27% sees volatility after terminating merger agreement; XPOF -6% falls on secondary offeringAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: CARS +3.9% (announced CFO transition and reaffirmed Q1 and FY22 guidance), SUPN +3.6% (reaffirmed FY22 guidance)
Companies trading higher in after hours in reaction to news: ANY +26.7% (mutually agreed to terminate merger agreement with Gryphon Digital Mining), RCUS +11.3% (appointed to join S&P SmallCap 600), KSCP +6.5% (announced committed equity facility with B. Riley), TBPH +5.8% (announced results from Study 0170), LEV +5.6% (received order for 50 all-electric school buses from Autobus Campeau), CSTL +4.4% (agreed to acquire AltheaDx), CUK +2.7% (reported that March 28-April 3 was the busiest booking week in company history), BIIB +1.1% (presented new data from multiple sclerosis portfolio at AAN 2022)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: N/A
Companies trading lower in after hours in reaction to news: XPOF -6.1% (announced secondary offering of common stock by selling stockholders), TRIN -4.1% (announced public offering of common stock)
Gapping down
Select oil/gas related names showing early weakness:
- TTE -2.5%, BP -1.2%, SHEL -1.1%
Other news:
- CRIS -35.4% (FDA places clinical hold on TakeAim Leukemia Phase 1/2a study)
- WVE -7.9% (Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004)
- OCGN -5.2% (World Health Organization suspends Covaxin's supply through UN agencies, according to India Today)
- SBUX -2.8% (suspends stock buyback program)
- ALNY -1.9% (FDA has extended the review timeline of the New Drug Application for vutrisiran to allow for the review of newly added information related to the new secondary packaging and labeling facility)
- FREY -1.2% (announced the appointment of Oscar Brown to the position of Group Chief Financial Officer at FREYR Battery)
Analyst comments:
- HOLX -2.4% (downgraded to In-line from Outperform at Evercore ISI)
- BAX -2% (downgraded to Sell from Neutral at Goldman)
- CROX -2% (downgraded to Hold from Buy at Loop Capital)
- DGX -1.5% (downgraded to Neutral from Buy at Citigroup)
![]()
LGapping up
In reaction to earnings/guidance:
- CAMT +9.6%, PERI +6.6%
Select Chinese ADRs trading higher:
- BILI +9.7%, JD +5.2%, NIO +5.1%, XPEV +4.7%, BIDU +4.6%, BABA +4.1%, LI +4.1%, MOMO +3.8%, NTES +3.5%, .
Other news:
- TWTR +24.1% (Elon Musk discloses 9.2% passive stake)
- NIU +5% (reports Q1 sales volume increased 9.4% yr/yr)
- ISAA +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
- GATO +2.3% (Provides Bi-Weekly Status Report)
- IRTC +2.2% (reports Zio Shown to Prevent Hospital Admissions, Aid in Early Detection of AF)
- VERV +1.8% (reports durable and well-tolerated editing of ANGPTL3 gene out to more than 20 months in non-human primates for potential treatment of atherosclerotic cardiovascular disease)
- BBIO +1.4% (Presents Updated Results from Phase 2 Open-label Extension Study of Acoramidis in Transthyretin Amyloid Cardiomyopathy)
- TMHC +1.4% (positive Barrons article)
- LXRX +1.3% (reports Sotagliflozin Improved Outcomes in Patients With and Without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology's 71st Annual Scientific Session)
Analyst comments:
- DCP +1.3% (upgraded to Outperform from In-line at Evercore ISI)
![]()
Early premarket gappers
- Gapping up:
- TWTR +24.9%, BILI +11%, GATO +7.7%, CAMT +7.6%, NIO +6.9%, XPEV +6.5%, NIU +5.8%, JD +5.8%, BIDU +5.2%, LI +5.2%, BABA +5%, PERI +4.7%, MOMO +4.3%, NTES +3.9%, DLTR +3.8%, IRTC +2.2%, TMHC +1.7%, BBIO +1.4%, LXRX +1.3%, TSLA +1.3%, KR +1.3%, TPH +0.9%, NVS +0.8%, REGN +0.5%
- Gapping down:
- TTE -1.4%, SBUX -1.1%, SHEL -1%, BP -0.9%, BMY -0.6%
![]()
* Swedbank Raised to Buy at Citi; PT 170 kronor
>>> Down
* CareTech Cut to Hold at HSBC; PT 725 pence
>>> Initiation
* Aena Reinstated Equal-Weight at Barclays; PT 145 euros
>>> Call
* Ocado Price Target Cut at Kepler Amid Uncertain Macro Outlook